CAR T-cell therapy effective for chronic lymphocytic leukemia – Healio
CAR T-cell therapy effective for chronic lymphocytic leukemiaHealioCD19-specific chimeric antigen receptor-modified T-cell therapy induced durable molecular remissions in patients with high-risk chronic lymphocytic leukemia who had previous treatment f… Continue reading
